These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18468624)

  • 1. Restless legs syndrome as side effect of second generation antidepressants.
    Rottach KG; Schaner BM; Kirch MH; Zivotofsky AZ; Teufel LM; Gallwitz T; Messer T
    J Psychiatr Res; 2008 Nov; 43(1):70-5. PubMed ID: 18468624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restless legs syndrome induced by escitalopram: case report and review of the literature.
    Page RL; Ruscin JM; Bainbridge JL; Brieke AA
    Pharmacotherapy; 2008 Feb; 28(2):271-80. PubMed ID: 18225972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reboxetine adjunct for partial or nonresponders to antidepressant treatment.
    Rubio G; San L; López-Muñoz F; Alamo C
    J Affect Disord; 2004 Jul; 81(1):67-72. PubMed ID: 15183602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electroencephalographic abnormalities associated with antidepressant treatment: a comparison of mirtazapine, venlafaxine, citalopram, reboxetine, and amitriptyline.
    Sterr A; Padberg F; Amann B; Mergl R; Mulert C; Juckel G; Hegerl U; Pogarell O
    J Clin Psychiatry; 2006 Feb; 67(2):325-6. PubMed ID: 16566633
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Al-Adwani A
    Can J Psychiatry; 2005 Nov; 50(13):877; author reply 877-8. PubMed ID: 16483124
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
    Sung SC; Haley CL; Wisniewski SR; Fava M; Nierenberg AA; Warden D; Morris DW; Kurian BT; Trivedi MH; Rush AJ;
    J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restless legs syndrome induced by citalopram: a psychiatric emergency?
    Perroud N; Lazignac C; Baleydier B; Cicotti A; Maris S; Damsa C
    Gen Hosp Psychiatry; 2007; 29(1):72-4. PubMed ID: 17189751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of reboxetine and mirtazapine on driving simulator performance and psychomotor function in depressed patients.
    Brunnauer A; Laux G; David I; Fric M; Hermisson I; Möller HJ
    J Clin Psychiatry; 2008 Dec; 69(12):1880-6. PubMed ID: 19203476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Benazzi F
    Can J Psychiatry; 2005 Mar; 50(3):184. PubMed ID: 15830829
    [No Abstract]   [Full Text] [Related]  

  • 11. Restless legs syndrome induced by mirtazapine.
    Ağargün MY; Kara H; Ozbek H; Tombul T; Ozer OA
    J Clin Psychiatry; 2002 Dec; 63(12):1179. PubMed ID: 12530413
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluoxetine-mirtazapine interaction may induce restless legs syndrome: report of 3 cases from a clinical trial.
    Prospero-Garcia KA; Torres-Ruiz A; Ramirez-Bermudez J; Velazquez-Moctezuma J; Arana-Lechuga Y; Teran-Perez G
    J Clin Psychiatry; 2006 Nov; 67(11):1820. PubMed ID: 17196069
    [No Abstract]   [Full Text] [Related]  

  • 13. Mirtazapine-induced worsening of restless legs syndrome (RLS) and ropinirole-induced psychosis: challenges in management of depression in RLS.
    Chopra A; Pendergrass DS; Bostwick JM
    Psychosomatics; 2011; 52(1):92-4. PubMed ID: 21300203
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mirtazapine versus other antidepressive agents for depression].
    Knud Larsen J
    Ugeskr Laeger; 2012 Nov; 174(46):2864-6. PubMed ID: 23153468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does domperidone potentiate mirtazapine-associated restless legs syndrome?
    Chang CC; Shiah IS; Chang HA; Mao WC
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):316-8. PubMed ID: 16309808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mirtazapine versus selective serotonin reuptake inhibitors.
    Thompson C
    J Clin Psychiatry; 1999; 60 Suppl 17():18-22; discussion 46-8. PubMed ID: 10446737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants.
    Kühn KU; Quednow BB; Thiel M; Falkai P; Maier W; Elger CE
    Epilepsy Behav; 2003 Dec; 4(6):674-9. PubMed ID: 14698701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression.
    Kent JM
    Lancet; 2000 Mar; 355(9207):911-8. PubMed ID: 10752718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are antidepressants safe for adolescents?
    Winters NC
    Postgrad Med; 2005 Sep; 118(3):33-4. PubMed ID: 16201306
    [No Abstract]   [Full Text] [Related]  

  • 20. Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
    Thase ME; Nierenberg AA; Vrijland P; van Oers HJ; Schutte AJ; Simmons JH
    Int Clin Psychopharmacol; 2010 Jul; 25(4):189-98. PubMed ID: 20531012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.